Increased levels of androgen precursors in the urine were found in 71% of ACC patients and 2% of ACA patients, whereas increased levels of DHEAS in the serum were only found in 42% of ACC patients and 2% of ACA patients. This evidence concerns the gene SULT2A1 and adrenal cortex carcinoma.